According to AlphaMoat, in October 2026 Generate Biomedicines (generatebiomedicines.com) received 26,575 monthly visits (+29.5% MoM) — ranked #6,633 of 17,609 AI websites with traffic data, and #853 of 3,112 in Industry Services; its largest market is United States (89.4% of visits).
Generate Biomedicines is a drug-discovery company built on generative biology, fusing machine learning, bioengineering, and medicine to design novel protein therapeutics with specific therapeutic functions from first principles.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 19.3K | — |
| 2026-07 | 21.5K | +11.5% |
| 2026-08 | 20.0K | -6.8% |
| 2026-09 | 20.5K | +2.4% |
| 2026-10 | 26.6K | +29.5% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, Generate Biomedicines (generatebiomedicines.com) received 26,575 visits (about 26.6K) in October 2026 (+29.5% month over month), ranking #6,633 of 17,609 AI websites with traffic data, and #853 in Industry Services.
In October 2026, Generate Biomedicines’s largest markets by share of visits are United States 89.4%, UK 8.3%, Canada 1.6%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.